Lemaitre Vascular News (NASDAQ:LMAT)
| Latest Lemaitre Vascular News Headlines | | Date | Time | Source | | | 06/04/2008 | 4:46PM | PRNUS | LeMaitre Vascular to Participate in 29th Annual Goldman Sachs Global Healthcare Conference
BURLINGTON, Mass., June 4 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate in the Twenty-Ninth Annual Goldman Sachs Health Care Conference on Tuesday, June... More...>> |
| 04/30/2008 | 4:05PM | PRNUS | LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
BURLINGTON, Mass., April 30 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), a provider of peripheral vascular devices and implants, today announced financial results for Q1 2008. Q1 2008 revenues were $11.8 million, an increase of 20% over Q1 2007.
Q1 2008 revenues increased 5% in the Company's endovascular... More...>> |
| 04/18/2008 | 1:33PM | PRNUS | LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
BURLINGTON, Mass., April 18 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its 2008 first quarter financial results on April 30, 2008, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The... More...>> |
| 04/10/2008 | 4:21PM | PRNUS | LeMaitre Vascular Announces Changes to Its Executive Management Team
BURLINGTON, Mass., April 10 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) today announced the departure of Kevin D. Kelly, Senior Vice President, North American Sales, to pursue other business opportunities and the appointment of Robert V. Linden to Vice President, North American Sales.
Mr. Linden... More...>> |
| 03/11/2008 | 2:13PM | PRNUS | LeMaitre Vascular to Participate in 28th Annual Cowen and Company Health Care Conference
BURLINGTON, Mass., March 11 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate in the 28th Annual Cowen and Company Health Care Conference on Tuesday, March... More...>> |
| 03/04/2008 | 4:05PM | PRNUS | LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
BURLINGTON, Mass., March 4 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), a provider of peripheral vascular devices and implants, today announced financial results for Q4 2007 and the year ended December 31, 2007. Q4 2007 revenues were $11.1 million, an increase of 27% over Q4 2006. 2007 revenues were... More...>> |
| 02/22/2008 | 4:07PM | PRNUS | LeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
BURLINGTON, Mass., Feb. 22 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its 2007 fourth quarter and full year financial results on March 4, 2008, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00... More...>> |
| 12/21/2007 | 12:32AM | PRNUS | LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
BURLINGTON, Mass., Dec. 21 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), a provider of peripheral vascular devices and implants, yesterday acquired Biomateriali S.r.l., a privately held Italian vascular graft manufacturer, for euro 1.8 million in cash, the assumption of euro 0.8 million in intercompany... More...>> |
| 12/17/2007 | 6:01PM | PRNUS | LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
BURLINGTON, Mass., Dec. 17 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) (the "Company") today announced that Russell D. Hays has been appointed to its Board of Directors, effective as of January 1, 2008. Mr. Hays will serve as a Class II director, standing for election at the next annual meeting of... More...>> |
| 11/16/2007 | 4:18PM | PRNUS | LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
BURLINGTON, Mass., Nov. 16 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) today announced the commercial launch of the TT(TM) Tortuous Tracker Delivery System, the next-generation introducer for LeMaitre Vascular's EndoFit(R) and UniFit(TM) Aortic Stent Graft product lines. The new delivery system will... More...>> |
| 11/08/2007 | 3:32PM | PRNUS | LeMaitre Vascular Hosting First Analyst Day
BURLINGTON, Mass., Nov. 8 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, will be hosting its first ever Analyst Day at the Marriott Marquis Hotel in New York City, on Monday, November... More...>> |
| 11/07/2007 | 10:20AM | PRNUS | LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference
BURLINGTON, Mass., Nov. 7 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate at the Canaccord Adams inaugural Cardiovascular Conference on Tuesday, November... More...>> |
| 11/05/2007 | 4:05PM | PRNUS | LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19% Increase
BURLINGTON, Mass., Nov. 5 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) (the "Company"), a provider of peripheral vascular devices and implants, today announced Q3 2007 financial results. Revenues for Q3 2007 were $10.1 million, an increase of 19% over Q3 2006.
Q3 2007 revenues increased 33% in the... More...>> |
| 10/31/2007 | 4:51PM | PRNUS | LeMaitre Vascular Receives Confirmatory Response to Its Prior Notification of Nasdaq
BURLINGTON, Mass., Oct. 31 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) (the "Company") today announced that it received a letter on October 26, 2007, from The Nasdaq Stock Market ("Nasdaq") in response to notice from the Company that the Company is not in compliance with Nasdaq's independent director... More...>> |
| 10/22/2007 | 11:59AM | PRNUS | LeMaitre Vascular, Inc. Schedules Third Quarter Results and Conference Call
BURLINGTON, Mass., Oct. 22 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its 2007 third quarter financial results on November 5, 2007, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The... More...>> |
| 10/19/2007 | 5:07PM | PRNUS | LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
BURLINGTON, Mass., Oct. 19 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), which develops, manufactures and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate at the CIBC 18th Annual Healthcare Conference on Tuesday, November 6, 2007, in... More...>> |
| 10/01/2007 | 5:23PM | PRNUS | LeMaitre Vascular to Start Italian Sales Force
BURLINGTON, Mass., Oct. 1 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc., (NASDAQ:LMAT), a provider of peripheral vascular devices and implants, today announced that it has reached an agreement to launch a direct sales force in Italy in January 2008.
LeMaitre Vascular currently sells its products in Italy through... More...>> |
| 09/20/2007 | 9:02PM | PRNUS | LeMaitre Vascular Acquires Vascular Architects
BURLINGTON, Mass., Sept. 20 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc., (NASDAQ:LMAT), a provider of peripheral vascular devices and implants, today acquired the business of Vascular Architects, a privately-held medical device company, for $2.8 million. Vascular Architects markets and sells devices for Remote... More...>> |
| 08/24/2007 | 1:59PM | PRNUS | LeMaitre Vascular to Participate at Thomas Weisel Partners Annual Healthcare Conference 2007
BURLINGTON, Mass., Aug. 24 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), which develops, manufactures and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate at the Thomas Weisel Partners Annual Healthcare Conference 2007 on Friday, September... More...>> |
| 08/01/2007 | 4:05PM | PRNUS | LeMaitre Vascular Reports Q2 2007 Revenue of $10.3 Million, an 18% Increase
BURLINGTON, Mass., Aug. 1 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), a provider of peripheral vascular devices and implants, today announced Q2 2007 financial results. Revenues for Q2 2007 were $10.3 million, a quarterly record, and an increase of 18% versus Q2 2006.
Q2 2007 revenues increased... More...>> |
|
|
|